Rapid Screening for Elemental Impurities using ICP-MS

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-11-15-2014
Volume 2014 eBook
Issue 3

The authors describe a rapid, single-point calibration approach for ICP–MS analysis of raw materials used in drug product manufacturing.

 

The official implementation of United States Pharmacopeia (USP) <232> will require measurement of elemental impurities using inductively coupled plasma–mass spectrometry (ICP–MS). The authors describe a rapid, single-point calibration approach for ICP–MS analysis of raw materials used in drug product manufacturing.

 

Download Pharmaceutical Technology’s

2014 Analytical and Bioanalytical Testing eBook

.



 

Articles in this issue
PTebook1114_Viral_185.jpg
The Challenge of Finding the Unknown
PTebook1114_MethodTransfer_185.jpg
Keys to Successful Method Transfer
PTebook1114__AQbD185.jpg
AQbD Adds Rigor to Method Development
PTebook1114_SGS_185.jpg
Validation of a Multiplex Bead-Based Assay
PTebook1114_PerkinElmer_185.jpg
Rapid Screening for Elemental Impurities using ICP-MS
PTebook1114_Allotrope_185.jpg
Standardizing Data Management
PTebook1114_0Products.jpg
Advances in Analytical Technology
Recent Videos
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

EMA’s CHMP Gives Positive Opinion for Use of Lecanemab in Early Alzheimer’s Disease

Felicity Thomas
November 16th 2024
Article

CHMP has granted Eisai Europe and Biogen a positive opinion for the use of their monoclonal antibody therapy in treating early Alzheimer’s disease.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Avantor Sees Future of Opportunities with Growing Development of Next-Gen Biotherapeutics

Feliza Mirasol
November 15th 2024
Article

Executives at Avantor talk about the future of the biopharmaceutical industry and the anticipated impact that a wave of next-generation biotherapeutics will bring.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

MD Anderson Launches Cell Therapy Institute

Susan Haigney
November 11th 2024
Article

The new Institute for Cell Therapy Discovery and Innovation will utilize expertise to develop cell therapies for cancer, autoimmune diseases, and infections.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Bespak and Orbia Fluor & Energy Materials Collaborate on Climate-Friendly Inhalers

Susan Haigney
November 8th 2024
Article

The companies will work to create climate-friendly pMDIs using Orbia’s low global warming potential propellant.